Clinical Application of Phage Immunoprecipitation Sequencing to Diagnose Enterovirus D68 as the Underlying Etiology in a Case of Guillain-Barré Syndrome - Report - MDSpire
Advertisement
Clinical Application of Phage Immunoprecipitation Sequencing to Diagnose Enterovirus D68 as the Underlying Etiology in a Case of Guillain-Barré Syndrome
Phage Immunoprecipitation Sequencing Links Enterovirus D68 to Guillain-Barré Syndrome
Overview
Phage immunoprecipitation sequencing (PhIP-Seq) was utilized to detect cerebrospinal fluid antibodies against enterovirus D68 (EV-D68) in a pediatric Guillain-Barré syndrome (GBS) case, supporting EV-D68 as an antecedent infectious trigger. This approach enabled etiological diagnosis where conventional molecular testing was inconclusive.
Background
Guillain-Barré syndrome (GBS) is an acute peripheral neuropathy characterized by ascending flaccid paralysis, often following respiratory or gastrointestinal infections. The pathogenesis involves immune-mediated nerve damage triggered by molecular mimicry after infection. Common infectious agents include Campylobacter jejuni and various viruses, with recent evidence implicating EV-D68. Diagnosing antecedent infections is challenging due to low pathogen detection in cerebrospinal fluid (CSF) during neurologic symptom onset.
Data Highlights
A 6-year-old female presented with progressive ascending weakness and cranial nerve involvement following EV-D68 respiratory infection confirmed by PCR. PhIP-Seq detected intrathecal antibodies against enterovirus D in CSF, correlating with clinical GBS diagnosis. Control specimens included CSF from neurologic patients with negative viral testing and sera from EV-D68 PCR-confirmed respiratory cases without neurologic symptoms.
Key Findings
GBS is often preceded by infections, but direct pathogen detection in CSF is frequently negative due to timing and low pathogen load.
PhIP-Seq enables detection of intrathecal antibody production against specific pathogens, providing evidence of antecedent infection.
In the reported pediatric case, PhIP-Seq identified anti-enterovirus D antibodies in CSF, linking EV-D68 respiratory infection to GBS onset.
Clinical presentation included progressive ascending weakness, cranial nerve palsy, and respiratory failure requiring intensive care.
PhIP-Seq may improve etiological diagnosis of GBS and other acute flaccid paralysis cases where conventional testing is inconclusive.
Clinical Implications
PhIP-Seq offers a valuable diagnostic tool to detect intrathecal antibody responses in GBS patients, facilitating identification of antecedent infectious triggers such as EV-D68. This can guide clinical management and epidemiological understanding of GBS etiology, especially when standard CSF pathogen detection methods fail. Early recognition of EV-D68 involvement may influence monitoring and supportive care strategies in pediatric GBS cases.
Conclusion
Phage immunoprecipitation sequencing successfully identified EV-D68 antibodies in CSF, supporting its role as a contributing factor in GBS. This method enhances diagnostic accuracy for infection-associated neurologic syndromes where direct pathogen detection is limited.
References
Original Article -- Utilization of Phage Immunoprecipitation Sequencing for Diagnosing Enterovirus D68 as a Contributing Factor in Guillain-Barré Syndrome Cases
by Fang Fang Li, Alison Faber, Jessica M Caleta, David M Goldfarb, Inna Sekirov, Natalie A Prystajecky, Jocelyn A Srigley, Ram Mishaal, Agatha N Jassem